Which pharmaceutical companies can source innovation from all three power centers?
Understanding BIOSECURE Impact
Unrestricted: Can partner with Chinese CROs, license innovations, acquire biotechs globally without regulatory constraints
Potentially Constrained: Senate BIOSECURE targets BGI/MGI (DoD 1260H list). House reconciliation could expand to WuXi entities affecting 79% of US biopharma